Unintended consequences for patients of future personalized pharmacoprinting

Susanne Kaae; Johanna Lena Maria Lind; Natalja Genina; Sofia Kälvemark Sporrong

doi:10.1007/s11096-018-0596-x

Unintended consequences for patients of future personalized pharmacoprinting

Susanne Kaae, Johanna Lena Maria Lind, Natalja Genina, Sofia Kälvemark Sporrong

10 Citations (Scopus)

Abstract

Manufacturing pharmaceuticals by the use of 3D printing is a promising way to achieve more personalized drug treatment. To effectively use this technology, patients need to continuously measure their health, and new decisions have to be taken, for example, regarding the number of daily drugs including how many active pharmaceutical substances these should contain along with decisions around size, shape and color. Positive as well as negative effects of pharmacoprinted medicine on patients are likely to occur. Negative consequences with influence on patient autonomy and role might include: patients not being capable or interested in conducting self-monitoring, loosing overview of the medical treatment, reducing the ability to perform self-regulation, loosing trust in the pharmacoprinted medicine, and not being interested in taking on a new role in medical decision making. These issues are discussed in the paper in order to prevent upcoming challenges in the area of pharmacoprinting.

Original language	English
Journal	International Journal of Clinical Pharmacy
Volume	40
Issue number	2
Pages (from-to)	321–324
ISSN	2210-7703
DOIs	https://doi.org/10.1007/s11096-018-0596-x
Publication status	Published - 1 Apr 2018

Access to Document

10.1007/s11096-018-0596-x

Cite this

@article{de53d408e87645459b915a6420e89b01,

title = "Unintended consequences for patients of future personalized pharmacoprinting",

abstract = "Manufacturing pharmaceuticals by the use of 3D printing is a promising way to achieve more personalized drug treatment. To effectively use this technology, patients need to continuously measure their health, and new decisions have to be taken, for example, regarding the number of daily drugs including how many active pharmaceutical substances these should contain along with decisions around size, shape and color. Positive as well as negative effects of pharmacoprinted medicine on patients are likely to occur. Negative consequences with influence on patient autonomy and role might include: patients not being capable or interested in conducting self-monitoring, loosing overview of the medical treatment, reducing the ability to perform self-regulation, loosing trust in the pharmacoprinted medicine, and not being interested in taking on a new role in medical decision making. These issues are discussed in the paper in order to prevent upcoming challenges in the area of pharmacoprinting.",

author = "Susanne Kaae and Lind, {Johanna Lena Maria} and Natalja Genina and {K{\"a}lvemark Sporrong}, Sofia",

year = "2018",

month = apr,

day = "1",

doi = "10.1007/s11096-018-0596-x",

language = "English",

volume = "40",

pages = "321–324",

journal = "International Journal of Clinical Pharmacy",

issn = "2210-7703",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Unintended consequences for patients of future personalized pharmacoprinting

AU - Kaae, Susanne

AU - Lind, Johanna Lena Maria

AU - Genina, Natalja

AU - Kälvemark Sporrong, Sofia

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Manufacturing pharmaceuticals by the use of 3D printing is a promising way to achieve more personalized drug treatment. To effectively use this technology, patients need to continuously measure their health, and new decisions have to be taken, for example, regarding the number of daily drugs including how many active pharmaceutical substances these should contain along with decisions around size, shape and color. Positive as well as negative effects of pharmacoprinted medicine on patients are likely to occur. Negative consequences with influence on patient autonomy and role might include: patients not being capable or interested in conducting self-monitoring, loosing overview of the medical treatment, reducing the ability to perform self-regulation, loosing trust in the pharmacoprinted medicine, and not being interested in taking on a new role in medical decision making. These issues are discussed in the paper in order to prevent upcoming challenges in the area of pharmacoprinting.

AB - Manufacturing pharmaceuticals by the use of 3D printing is a promising way to achieve more personalized drug treatment. To effectively use this technology, patients need to continuously measure their health, and new decisions have to be taken, for example, regarding the number of daily drugs including how many active pharmaceutical substances these should contain along with decisions around size, shape and color. Positive as well as negative effects of pharmacoprinted medicine on patients are likely to occur. Negative consequences with influence on patient autonomy and role might include: patients not being capable or interested in conducting self-monitoring, loosing overview of the medical treatment, reducing the ability to perform self-regulation, loosing trust in the pharmacoprinted medicine, and not being interested in taking on a new role in medical decision making. These issues are discussed in the paper in order to prevent upcoming challenges in the area of pharmacoprinting.

U2 - 10.1007/s11096-018-0596-x

DO - 10.1007/s11096-018-0596-x

M3 - Journal article

C2 - 29380235

SN - 2210-7703

VL - 40

SP - 321

EP - 324

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

IS - 2

ER -

Unintended consequences for patients of future personalized pharmacoprinting

Abstract

Access to Document

Fingerprint

Cite this